Skip to main content
. 2022 Mar 1;9(2):275–287. doi: 10.3233/JND-210741

Table 1.

Demographics of WSiMD participants

Subject Age Decade Sex Race Dx Gene Dose Ambulatory
01 4th M WNH LGMD ANO5 85 mg Yes
02 4th M WNH LGMD ANO5 65 mg Yes
03 5th M WNH BMD DMD 60 mg No
04 3rd F WH LGMD CAPN3 55 mg Yes
05 6th F WNH LGMD FKRP 55 mg No
06 3rd F WNH LGMD SGCG 50 mg No
07 3rd M WNH LGMD FKRP 55 mg No
08 5th M SAI LGMD DYSF 55 mg No
09 4th F WH LGMD DYSF 65 mg Yes
10 5th M AA LGMD DYSF 60 mg No
11 3rd F WH LGMD CAPN3 70 mg Yes
12 5th M WNH LGMD CAPN3 60 mg No
13 3rd M WNH LGMD CAPN3 45 mg Yes
14 7th M WH LGMD ANO5 80 mg Yes
15 5th M WNH LGMD CAPN3 65 mg Yes
16 3rd M WNH LGMD TTN 70 mg No
17 5th M WNH LGMD CAPN3 70 mg Yes
18 2nd M WNH LGMD CAPN3 45 mg Yes
19 3rd F WNH LGMD CAPN3 60 mg Yes
20 3rd F WNH LGMD FKRP 60 mg Yes

WNH: White Non-Hispanic. WH: White Hispanic. SAI: South Asian Indian. AA: African American.